Healthcare Leader: Pneumococcal Vaccine Shared Decision-Making Guide...Plus, Latest Covid-19 Stats...How Does Your Community Measure Up?

March 23, 2023

Vaccination Beyond COVID-19

Shared Decision-Making Guide for PCV20 Vaccination Against Pneumococcal Disease

Adults over the age of 65 may be at increased risk of exposure to pneumococcal disease and may be at heightened risk of severe disease if they are immunocompromised or have one or more chronic health conditions. If it has been five years or more since their previous pneumococcal vaccination and they fall into a high-risk group, these adults may have the option of receiving the PCV20 Vaccine to offer further protection.

Download the CDC's Shared Decision-Making Guide to help inform your discussion about the risks and benefits of this important vaccine.

Weekly COVID-19 Snapshot

Check Your Community's Stats

Download these resources to support your work:

Next week we have an array of educational opportunities. Take advantage of our 30-minute online sessions on topics that are important to you. Please visit our calendar to learn more and register.

Visit our website
Email us
Call us toll-free at 888-502-0566

Visit Our Resource Library

Join Our Network

www.qi.ipro.org

The IPRO QIN-QIO works to ensure high-quality, safe health care in New England, New York, New Jersey, Ohio, Delaware, Maryland, and the District of Columbia.

This material was prepared by the IPRO QIN-QIO, a Quality Innovation Network-Quality Improvement Organization, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services (HHS). Views expressed in this document do not necessarily reflect the official views or policy of CMS or HHS, and any reference to a specific product or entity herein does not constitute endorsement of that product or entity by CMS or HHS. 12SOW-IPRO-QIN-T1-AA-21-435